8-KItem 5.02 · Officer/Director ChangeItem 5.07 · Shareholder VoteItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Medtronic names Michael Marinaro president as MiniMed separation closes
Filed with the SEC on · Summarized by InvestorsBot
Medtronic appointed Michael Marinaro president effective October 14, 2026, while he continues leading Medical Surgical, Americas and global commercial operations and adds oversight of Greater China; his fiscal 2027 base salary rises to $1 million, with a 100% target incentive and approximately $3.25 million in supplemental long-term awards. Medtronic also completed the separation of MiniMed Group on October 15 after exchanging its remaining 252.8 million MiniMed shares in an offer that was 5.4 times subscribed.